Carlos Pedraza
About Carlos Pedraza
Carlos Pedraza is the Director of CNS Biology at Alkermes in Waltham, Massachusetts, with extensive experience in neuroimmunology and neurodegenerative diseases.
Current Role at Alkermes
Carlos Pedraza serves as the Director of CNS Biology at Alkermes in Waltham, Massachusetts, United States. In this role, he is responsible for leading the central nervous system (CNS) biology team. His responsibilities include overseeing research, strategy development, and the execution of projects related to neurobiology. His work involves leveraging his extensive expertise in neurological disorders to advance Alkermes' pipeline.
Past Experience at Sanofi
From 2017 to 2021, Carlos Pedraza worked at Sanofi as the Associate Director of Neuroimmunology and MS Therapeutics. During his four-year tenure in the United States, he contributed significantly to the company's neuroimmunology programs, focusing on Multiple Sclerosis (MS) therapies. His role involved the development and implementation of research strategies to advance MS treatments.
Academic and Early Career Background
Carlos Pedraza began his postdoctoral research career at the University of Lleida in Catalonia, Spain, where he served as a Postdoctoral Fellow from 2003 to 2005. He then moved to the Cleveland Clinic, holding the position of Postdoctoral Research Fellow for four years, from 2005 to 2009. Following this, he joined the University of Colorado Denver as a Postdoctoral Research Fellow and Lab Manager from 2009 to 2010. These roles laid the foundation for his expertise in neuroimmunology and CNS biology.
Educational Background in Neuroimmunology
Carlos Pedraza earned his Doctor of Philosophy (PhD) in Neuroimmunology from the Universitat Autònoma de Barcelona. He completed his studies from 1997 to 2002. His academic training provided him with a solid foundation in neuroimmunology, equipping him with the skills necessary for his research on neurodegenerative disorders and autoimmune diseases.
Expertise in High-Throughput Cellular Assays and Neurodegenerative Diseases
Carlos Pedraza has extensive experience in developing and optimizing high-throughput cellular assays for phenotypic screening. His expertise lies in neurodegenerative diseases such as Alzheimer's, Parkinson's, and Multiple Sclerosis. Additionally, he has worked extensively on autoimmune diseases including Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis (RA), and asthma. His role involves providing timely presentations of data and scientific results, showcasing his dynamic and team-oriented approach.
Evaluation of Scientific Assets for In-Licensing and Partnerships
In his career, Carlos Pedraza has been actively involved in the evaluation of potential external scientific assets for in-licensing and partnering with both academic and industry institutions. This involves assessing scientific research, identifying promising assets, and fostering collaborations to drive innovative solutions and therapeutic developments.